ProfileGDS4718 / 243238_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 18% 22% 17% 28% 28% 23% 22% 18% 30% 22% 28% 34% 34% 19% 29% 17% 26% 20% 19% 37% 19% 26% 17% 24% 29% 22% 29% 21% 31% 41% 35% 20% 29% 24% 25% 27% 36% 31% 26% 15% 23% 39% 23% 16% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.0824618
GSM549102patient 115, normal, homogenized [OPG study]4.2345122
GSM549104patient 119, normal, homogenized [OPG study]4.0029317
GSM549108patient 138, normal, homogenized [OPG study]4.4877228
GSM549119patient 077, normal, homogenized [OPG study]4.4585428
GSM549133patient 032, cancer, homogenized [OPG study]4.2056523
GSM549139patient 042, cancer, homogenized [OPG study]4.1971522
GSM549099patient 107, normal, homogenized [OPG study]4.092218
GSM549109patient 139, normal, homogenized [OPG study]4.5797730
GSM549110patient 046, normal, homogenized [OPG study]4.2052922
GSM549114patient 063, normal, homogenized [OPG study]4.4119628
GSM549122patient 082, normal, homogenized [OPG study]4.7227634
GSM549134patient 033, cancer, homogenized [OPG study]4.6900234
GSM549136patient 036, cancer, homogenized [OPG study]4.0429419
GSM549140patient 044, cancer, homogenized [OPG study]4.4434429
GSM549111patient 047, normal, homogenized [OPG study]4.0234317
GSM549113patient 057, normal, homogenized [OPG study]4.3058226
GSM549132patient 031, cancer, homogenized [OPG study]4.1284920
GSM549137patient 038, cancer, homogenized [OPG study]4.0986919
GSM549142patient 047, cancer, homogenized [OPG study]4.9917837
GSM549100patient 110, normal, homogenized [OPG study]4.1355119
GSM549107patient 135, normal, homogenized [OPG study]4.3599926
GSM549115patient 068, normal, homogenized [OPG study]3.9905817
GSM549116patient 072, normal, homogenized [OPG study]4.290124
GSM549120patient 078, normal, homogenized [OPG study]4.5080829
GSM549131patient 030, cancer, homogenized [OPG study]4.1685422
GSM549118patient 074, normal, homogenized [OPG study]4.4920529
GSM549129patient 027, cancer, homogenized [OPG study]4.1834821
GSM549123patient 088, normal, homogenized [OPG study]4.5617131
GSM549124patient 006, cancer, homogenized [OPG study]5.0747741
GSM549126patient 015, cancer, homogenized [OPG study]4.7376435
GSM549128patient 025, cancer, homogenized [OPG study]4.1319620
GSM549103patient 117, normal, homogenized [OPG study]4.5456929
GSM549117patient 073, normal, homogenized [OPG study]4.2862724
GSM549138patient 041, cancer, homogenized [OPG study]4.317825
GSM549141patient 045, cancer, homogenized [OPG study]4.3569527
GSM549130patient 028, cancer, homogenized [OPG study]4.8257336
GSM549101patient 111, normal, homogenized [OPG study]4.6045431
GSM549105patient 128, normal, homogenized [OPG study]4.4119926
GSM549106patient 134, normal, homogenized [OPG study]3.9135315
GSM549112patient 048, normal, homogenized [OPG study]4.2537623
GSM549125patient 011, cancer, homogenized [OPG study]4.9340739
GSM549127patient 024, cancer, homogenized [OPG study]4.2478523
GSM549135patient 035, cancer, homogenized [OPG study]3.9446816